Cargando…
Risk of Guillain–Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany†
PURPOSE: A prospective, epidemiologic study was conducted to assess whether the 2009 pandemic influenza A(H1N1) vaccination in Germany almost exclusively using an AS03-adjuvanted vaccine (Pandemrix) impacts the risk of Guillain–Barré syndrome (GBS) and its variant Fisher syndrome (FS). METHODS: Pote...
Autores principales: | Prestel, Jürgen, Volkers, Peter, Mentzer, Dirk, Lehmann, Helmar C, Hartung, Hans-Peter, Keller-Stanislawski, Brigitte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282476/ https://www.ncbi.nlm.nih.gov/pubmed/24817531 http://dx.doi.org/10.1002/pds.3638 |
Ejemplares similares
-
Rare cases of Guillain-Barré syndrome after COVID-19 vaccination, Germany, December 2020 to August 2021
por: Lehmann, Helmar C, et al.
Publicado: (2023) -
Adverse events following immunisation with a meningococcal serogroup B vaccine: report from post-marketing surveillance, Germany, 2013 to 2016
por: Mentzer, Dirk, et al.
Publicado: (2018) -
Could symptom overlap of COVID-19 and Guillain–Barré syndrome mask an epidemiological association?
por: Svačina, Martin K. R., et al.
Publicado: (2021) -
Guillain-Barré Syndrome Surveillance during National Influenza Vaccination Campaign, New York, USA, 2009
por: Giambrone, Gregory P., et al.
Publicado: (2013) -
Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe
por: Dieleman, Jeanne, et al.
Publicado: (2011)